Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01626898 · ClinicalTrials.gov registry record · NA

HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention

A NA study, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
NA
Development phase
304
Enrollment target

NCT01626898 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 304 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01626898, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
NA
Development phase
304 participants
Enrollment target

Study Summary

Wake Forest University is partnering with Chatham Social Health Council (a community-based organization) to conduct a randomized controlled trial to evaluate the efficacy of Hombres Ofreciendo Liderazgo y Apoyo (HOLA) en Grupos (Men Giving Leadership and Support in Groups), a Spanish-language HIV risk behavior intervention for Latino men who have sex with men (MSM) in rural North Carolina. Participants in the HOLA intervention, when compared to those in the comparison intervention, will report: increased consistent use of condoms during sexual intercourse; increased use of HIV and sexually transmitted disease (STD) counseling, testing, and treatment services; greater knowledge concerning the impact of HIV on communities (including Latino and MSM)and HIV risk behaviors and prevention strategies; more positive attitudes towards abstinence and condom use; increased self-efficacy to use and assert the use of condoms with sex partners; increased condom-use mastery scores; decreased barriers to risk reduction (e.g. health-compromising aspects of machismo); and enhanced partner and provider communication and sexual negotiation skills.

Interventions

  • BEHAVIORAL HOLA en Grupos
  • BEHAVIORAL General Health intervention (comparison intervention )

Trial Details

FieldValue
Enrollment Target 304 participants
Start Date 2012-08
Est. Completion 2015-08
Phase NA

What the Registry Record Tells You About NCT01626898

The ClinicalTrials.gov registry entry for NCT01626898 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which HOLA en Grupos is the first listed.

NCT01626898 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01626898 about?

NCT01626898 is a clinical study titled "HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention". Wake Forest University is partnering with Chatham Social Health Council (a community-based organization) to conduct a randomized controlled trial to evaluate the efficacy of Hombres Ofreciendo Liderazgo y Apoyo (HOLA) en Grupos (Men Giving Leadership and Support in Groups), a Spanish-language HIV ri...

What is the current status of trial NCT01626898?

This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2012-08. Estimated completion is 2015-08.

What interventions are being tested in trial NCT01626898?

The interventions under investigation include: HOLA en Grupos (BEHAVIORAL), General Health intervention (comparison intervention ) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01626898?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.